ALAR PHARMACEUTICALS INC.
Update：2025/12/24
Industries
Main Industry
Biotechnology
Main Product/Service
Different from the current long-acting technologies, drug products developed by our unique long-acting release platform (In-Relar) have distinctive characteristics such as low viscosity solution, small injection volume, and sustained drug release profile,
Founded Year
2016
Unified Business No.
52310651
Status
Active
Number of Employees
0
Total Paid-in
Capital
668,000,000 (NT$)
Location of Company
Taiwan
, Taichung City
Exit Status
OTC listing(2025)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
Alar Pharmaceuticals Inc., established in 2016, is a new drug development company focusing on developing long-acting release drug products for CNS disorders and chronic diseases. Aiming to submit the new drug application via the 505(b)(2) regulatory pathw
